Evidence map›Paper›PMID 37763436›Full record

ReviewMaterials (Basel, Switzerland)2023

Zirconium Carbide for Hypersonic Applications, Opportunities and Challenges.

Glenn R Peterson, Ryan E Carr, Ernesto E Marinero

Open access · goldAbstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 21 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Glenn R PetersonSchool of Materials Engineering, Purdue University, West Lafayette, IN 47907, USA.
Ryan E CarrSchool of Materials Engineering, Purdue University, West Lafayette, IN 47907, USA.
Ernesto E MarineroSchool of Materials Engineering, Purdue University, West Lafayette, IN 47907, USA.ORCID 0000-0001-5316-9342
Purdue University West Lafayette · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At ultra-high temperatures, resilient, durable, stable material choices are limited. While Carbon/Carbon (C/C) composites (carbon fibers and carbon matrix phases) are currently the materials of choice, zirconium carbide (ZrC) provides an option in hypersonic environments and specifically in wing leading edge (WLE) applications. ZrC also offers an ultra-high melting point (3825 K), robust mechanical properties, better thermal conductivity, and potentially better chemical stability and oxidation resistance than C/C composites. In this review, we discuss the mechanisms behind ZrC mechanical, thermal, and chemical properties and evaluate: (a) mechanical properties: flexure strength, fracture toughness, and elastic modulus; (b) thermal properties: coefficient of thermal expansion (CTE), thermal conductivity, and melting temperature; (c) chemical properties: thermodynamic stability and reaction kinetics of oxidation. For WLE applications, ZrC physical properties require further improvements. We note that materials or processing solutions to increase its relative density through sintering aids can have deleterious effects on oxidation resistance. Therefore, improvements of key ZrC properties for WLE applications must not compromise other functional properties. We suggest that C/C-ZrC composites offer an engineering solution to reduce density (weight) for aerospace applications, improve fracture toughness and the mechanical response, while addressing chemical stability and stoichiometric concerns. Recommendations for future work are also given.

Indexed as

hypersonicsultra-high temperature ceramicsZrC

Identifiers

PMID37763436
PMCPMC10532790
OpenAlexW4386616698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.